Clinical Trials in Baltimore

Showing 14041-14060 of 20,142 trials

Investigating the Effect of Vortioxetine in Adult ADHD Patients

NCT02327013

The purpose is to determine the effect of vortioxetine treatment on ADHD symptoms in adult patients with ADHD in a 12 weeks study.

Attention Deficit Hyperactivity Disorder

H. Lundbeck A/S227 participantsStarted Dec 2014

Beverly Hills, California, United States • Garden Grove, California, United States • National City, California, United States +12 more locations

COMPLETEDPhase 2< 1 mile

Study of AKR-501 Tablets Taken Orally Once Daily for 28 Days in Patients With Chronic Idiopathic Thrombocytopenic Purpura (ITP)

NCT00441090

The purpose of this study is to determine the efficacy, safety and tolerability, of AKR-501 (avatrombopag) tablets, as compared to placebo, in the treatment of participants with chronic Idiopathic Thrombocytopenic Purpura (ITP).

Chronic Idiopathic Thrombocytopenic PurpuraPurpura, Thrombocytopenic, Idiopathic

Eisai Inc.64 participantsStarted Feb 2007

Anaheim, California, United States • Bakersfield, California, United States • Concord, California, United States +22 more locations

Investigating the Effect of Vortioxetine in Adult ADHD Patients

Study of AKR-501 Tablets Taken Orally Once Daily for 28 Days in Patients With Chronic Idiopathic Thrombocytopenic Purpura (ITP)

Find Trials by Condition in Baltimore

Motexafin Gadolinium, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma

Bortezomib and Thalidomide in Treating Patients With Newly Diagnosed Stage II or Stage III Multiple Myeloma

Assessment of Any Potential Retinal Effects of Tafenoquine (TQ)

Deflazacort Expanded Access Program for Children, Adolescents and Adults With Duchenne Muscular Dystrophy

Cardiovascular Improvements With MV ASV Therapy in Heart Failure

Diabetes Prevention Program

Study of Carfilzomib for Multiple Myeloma Patients Who Are Relapsed/Refractory to Bortezomib-containing Treatments

A Phase 1 Study Evaluating CB-5083 in Subjects With Lymphoid Hematological Malignancies

Continuation Study of Lapatinib Monotherapy or Lapatinib in Combination With Other Anti-cancer Agents

Long-term Follow-up of Participants From Studies Evaluating GSK HIV Vaccine

Safety, Preliminary Efficacy and Pharmacokinetics of ASN001 in Metastatic Castrate Resistant Prostate Cancer

Combination Therapy Compared With Single-Drug Therapy in Patients With Cardiac Diseases

Treatment of Thrombocytopenia in Patients With Chronic Liver DiseaseUndergoing an Elective Procedure

A Phase 1 Study Evaluating CB-5083 in Subjects With Advanced Solid Tumors

Third International Study on Mechanical Ventilation

Patient Real-world Clinical, Neurological, Tolerability, and Safety Outcomes for Tecfidera® and Rebif®

Can Valacyclovir Delay the Need for Initiation of Human Immunodeficiency Virus (HIV) Treatment in HIV-infected Individuals?

The Captivator EMR Registry